One of the first studies of real-world use of pneumococcal conjugate vaccine (PCV) in Africa, found 48% fewer cases of pneumonia in children confirmed by x-ray after PCV introductoin. The results show the vaccine greatly reduced childhood pneumonia hospital admissions in Kenya: Hospital admissions for pneumonia went down 27%.The vaccine led to 329 fewer pneumonia cases per 100,000 kids each year.
Full Citation:
Silaba M, Ooko M, Bottomley D, et al.. 2019. Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinical-defined pneumonia in Kenyan children: an interrupted time-series analysis. Lancet Global Health. 7.
Title of Article: Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinical-defined pneumonia in Kenyan children: an interrupted time-series analysis
Author(s): Silaba M, Ooko M, Bottomley D, et al.
Publication Year: 2019
Publication Name: Lancet Global Health
Publication Volume: 7
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/30784634/
DOI (Digital Object Identifier): 10.1016/S2214-109X(18)30491-1
Topics: Health System Strengthening
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Countries: Kenya
WHO Regions: Africa